Anti-phospholipase A2 and anti-inflammatory activity of Santolina chamaecyparissus

Life Sciences

Volumn 66, Issue 2, 1999, Pages

  Sala, Araceli ^a   Recio, M Carmen ^a   Giner, Rosa M ^a   Máñez, Salvador ^a   Ríos, José Luis ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Anti inflammatory activity; Anti phospholipase A2; Flavonoids; Santolina chamaecyparissus; Sesquiterpenes

Indexed keywords

DICHLOROMETHANE; FLAVONOID; METHANOL; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; SANTOLINA CHAMAECYPARISSUS EXTRACT; SESQUITERPENE DERIVATIVE;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG INHIBITION; DRUG ISOLATION; EDEMA; ENZYME INHIBITION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PAW EDEMA;

ANIMALIA; SANTOLINA CHAMAECYPARISSUS;

EID: 0033520868     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. 1. R.M. Giner, J.L. Ríos, and A. Villar, Phytother. Res. 2 37-41 (1988).
2. 2. J.L. Ríos, R.M., Giner and A. Villar, Phytother. Res. 3 212-214 (1989).
3. 3. M.J. Cuéllar, R.M. Giner, M.C. Recio, M.J. Just, S. Máñez, M. Cerdá and J.L. Ríos, Phytother. Res. 12 18-23 (1998).
4. 4. J.F. Sanz, A. García-Sarrión and J.A Marco, Phytochemistry 30 3339-3342 (1991).
5. 5. J.A. Marco, J.F. Sanz-Cervera, M. Carda and J. Lex, Phytochemistry 34 1549-1559 (1993).
6. 6. P.C.A. Neves, M.C.A. Neves, A. Bella Cruz, A.E.G. Sant'Ana, R.A. Yunes and J.B. Calixto, Eur. J. Pharmacol. 243 213-219 (1993).
7. 7. R. Brattsand, A. Thalén, K. Roempke, L. Källström and E. Gruvstad, J. Steroid Biochem. 16 779-786 (1982).
8. 8. J.M. Young and L.M. De Young, Pharmacological Methods in the Control of Inflammation, J. Spector and N. Back (Eds), 215-231, Alan R. Liss, New York, (1989).
9. 9. J.M. Young, D.A. Spires, C.J. Bedord, B. Wagner, S.J. Ballaron and L.M. De Young, J. Invest. Dermatol. 82 367-371 (1984).
10. 10. P.L. Stanley, S. Steiner, M. Havens and K.M. Tramposch, Skin Pharmacol. 4 262-271 (1991).
11. 11. L.M. De Young, J.B. Kheifets, S.J. Ballaron and J.M. Young, Agents Actions 26 335-341 (1989).
12. 12. M.J. Cuéllar, R.M. Giner, M.C. Recio, M.J. Just, S. Máñez and J.L. Ríos, J. Nat. Prod. 59 977-979 (1996).
13. 13. G. Cirino, S.H. Peers, J.L. Wallace and R.J. Flowers, Eur. J. Pharmacol. 166 505-510 (1989).
14. 14. G. Cirino, S.H. Peers, R.J. Flowers, J.L. Browning and R.B. Pepinsky. Proc. Natl. Acad. Sci. USA 86 3428-3432 (1989).
15. 15. M. Becchi and M. Carrier, Planta Med. 38 267-268 (1980).
16. 16. M.L. Ferrándiz, M.J. Sanz, G. Bustos, M. Payá, M.J. Alcaraz, and S. De Rosa, Eur. J. Pharmacol. 253 75-82 (1994).
17. 17. S. Máñez, M.C. Recio, I. Gil, C. Gómez, R.M. Giner, J.L. Ríos, and P.G. Waterman, J. Nat. Prod. 62 601-604 (1999).
18. 18. A. Nasiri, A. Holth, and L. Björk, Planta Med. 59 203-206 (1993).
19. 19. P. García, S. De Rosa, A. De Giulio, M. Payá, and M.J. Alcaraz, Br. J. Pharmacol. 126 301-311 (1999).
20. 20. J. Robak, F. Shridi, M. Wolbis, and M. Krolikowska, Pol. J. Pharmacol. 40 451-458 (1988)
21. 21. M.J. Sanz, M.L. Ferrándiz, M. Cejudo, M.C. Terencio, B. Gil, G. Bustos, A. Úbeda, R. Gunasegaran, and M.J. Alcaraz, Xenobiotica 24 689-699 (1994).